The prevalence of psoriasis in patients with CD and UC is 3.6% and 2.8%, respectively, while the prevalence of paradoxical psoriasis in IBD is 6.7%, stressing the impact of therapy with anti-TNF-α drugs on the development of this disease [3]. The gene discussed is TNF; the disease is psoriasis.